文献速递妇科

Bokhman再思考:21世纪子宫内膜癌的「类型」

Bokhman Redux: Endometrial cancer "types" in the 21st century.
PubMed 文献 · Gynecol Oncol · 2016-12-16

本文回顾了Bokhman于1983年提出的子宫内膜癌二元分类模型(I型与II型)的历史价值与后续验证,并指出近期大型流行病学研究提示肥胖与激素可能在整个组织学和临床谱系中起作用,高质量分子数据与病理分类的 refined 挑战了简单二分法,TCGA基于突变负荷、p53、POLE、PTEN突变、微卫星不稳定性和组织学定义了四种临床 distinct 的子宫内膜癌类型。

要点

  • Bokhman的I型与II型二分法在缺乏精细信息的大型登记数据库工作中仍有参考价值。
  • 近期大型流行病学研究提示肥胖和激素可能在整个子宫内膜癌组织学与临床谱系中起重要作用。
  • TCGA基于突变负荷、p53、POLE、PTEN突变、微卫星不稳定性和组织学定义了四种临床 distinct 类型。

核心结论

  • Bokhman的直觉性二元模型在缺乏精细信息的大型登记数据库工作中仍有参考价值;其他大多数工作应将临床、病理和分子细节整合为更细致的分类。

研究设计与样本

  • 本文为叙述性综述,回顾Bokhman于1983年发表的子宫内膜癌二元分类模型及相关后续文献。

主要发现

  • Bokhman于1983年发表里程碑论文提出子宫内膜癌的双重病原学类型,I型多为雌激素驱动的低级别子宫内膜样肿瘤,与肥胖及代谢综合征组分强相关,II型为高级别非子宫内膜样肿瘤,上述关联较不显著。
  • 该二分法的基本原则包括显著的预后差异已被后续文献大量证实,并为数十年的教学和跨学科科学进步提供了有用框架。
  • 近期大型流行病学研究提示肥胖和激素可能在整个子宫内膜癌组织学与临床谱系中起重要作用。
  • 癌症基因组图谱(TCGA)基于总体突变负荷、特定p53、POLE和PTEN突变、微卫星不稳定性及组织学定义了四种临床 distinct 的子宫内膜癌类型。
  • 具有明确预后意义的新组织学类别已被接受,从流行病学角度看代谢因素可能在整体子宫内膜癌中起重要作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 1983 Jan V. Bokhman, M.D. published a landmark paper entitled "Two Pathogenetic Types of Endometrial Carcinoma" in which an enduring dualistic view of endometrial cancer was first proposed. "Type I" cancers are thought to represent estrogen driven mostly low grade endometrioid tumors strongly associated with obesity and other components of the metabolic syndrome. "Type II" cancers represent higher grade non-endometrioid tumors for which the latter associations are less significant. Basic tenets of this dichotomy including significant prognostic differences have been abundantly confirmed by later literature. The construct has in turn contributed a useful framework for decades of teaching and scientific advancement across disciplines. However, recent large epidemiologic studies indicate a more complex web of risk factors with obesity and hormones likely playing an important role across the entire endometrial cancer histologic and clinical spectrum. Moreover, high quality molecular data and refinements in pathologic classification challenge any simplistic classification of endometrial cancer. For example, the Cancer Genome Atlas (TCGA) recently defined four clinically distinct endometrial cancer types based on their overall mutational burden, specific p53, POLE and PTEN mutations, microsatellite instability and histology. Additionally, new histologic categories with clear prognostic implications have been accepted and it is becoming evident from an epidemiologic point of view that metabolic factors may play an important role in endometrial cancer overall. While Bokhman's intuitive dualistic model remains relevant when working with large registries and databases lacking granular information; most other efforts should integrate clinical, pathological and molecular specifics into more nuanced classifications.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Suarez AA, Felix AS, Cohn DE, et al. Bokhman Redux: Endometrial cancer "types" in the 21st century. Gynecol Oncol. 2016. PMID: 27993480. doi:10.1016/j.ygyno.2016.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。